Previous studies have shown that knocking down MASTL in breast cancer, head and neck squamous cell carcinoma cell lines make them more susceptible to chemotherapy treatments circumventing the resistance problems. This evidence concerns the gene MASTL and head and neck squamous cell carcinoma.